These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20583535)

  • 1. Growth hormone testing nutrition and metabolic balance, do we have the full picture?
    Zadik Z
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):321. PubMed ID: 20583535
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children.
    Liang S; Yu Z; Song X; Wang Y; Li M; Xue J
    Horm Metab Res; 2018 Mar; 50(3):250-256. PubMed ID: 29341046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of tumor necrosis factor-alpha, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance.
    Blüher M; Kratzsch J; Paschke R
    Diabetes Care; 2001 Feb; 24(2):328-34. PubMed ID: 11213887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone secretion and insulin-like growth factor-1 are related to hyperandrogenism in nonobese patients with polycystic ovary syndrome.
    Premoli AC; Santana LF; Ferriani RA; Moura MD; De Sá MF; Reis RM
    Fertil Steril; 2005 Jun; 83(6):1852-5. PubMed ID: 15950665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral glucose administration on rebound growth hormone release in normal and obese women: the role of adiposity, insulin sensitivity and ghrelin.
    Pena-Bello L; Pertega-Diaz S; Outeiriño-Blanco E; Garcia-Buela J; Tovar S; Sangiao-Alvarellos S; Dieguez C; Cordido F
    PLoS One; 2015; 10(3):e0121087. PubMed ID: 25782001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated growth hormone concentrations in obese pediatric patients with mild and severe insulin resistance: a pilot study.
    Radack JA; White PC; Adams-Huet B; Oden JD
    J Pediatr Endocrinol Metab; 2010 Apr; 23(4):355-61. PubMed ID: 20583540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
    Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
    Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of simple childhood obesity on the components of the growth hormone-insulin-like growth factor (IGF)-IGF binding proteins axis.
    Ballerini MG; Ropelato MG; Domené HM; Pennisi P; Heinrich JJ; Jasper HG
    J Pediatr Endocrinol Metab; 2004 May; 17(5):749-57. PubMed ID: 15237710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of resting metabolic rate, self-rated food intake, growth hormone, and insulin levels in obese and nonobese preadolescents.
    Laessle RG; Wurmser H; Pirke KM
    Physiol Behav; 1997 May; 61(5):725-9. PubMed ID: 9145943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders.
    Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Hernández M
    Horm Res; 1997; 48 Suppl 4():16-8. PubMed ID: 9350440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity and hypercholesterolemia in patients with prolactinomas: Could DHEA-S and growth hormone be the missing link?
    Perić B; Kruljac I; Šundalić S; Pećina HI; Jović A; Štefanović M; Butorac D; Vrkljan M
    Endocr Res; 2016 Aug; 41(3):200-6. PubMed ID: 26864960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone on dawn phenomenon in patients with type 2 diabetes.
    Shih KC; Hsieh SH; Kwok CF; Hwu CM; Hsieh PS; Ho LT
    Growth Factors; 2013 Apr; 31(2):66-73. PubMed ID: 23452315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of elevated growth hormone on the increased atherosclerosis in patients with acromegaly.
    Rizzo M; Montalto G; Rizvi AA; Christ ER
    Angiology; 2012 Oct; 63(7):492-4. PubMed ID: 22371625
    [No Abstract]   [Full Text] [Related]  

  • 14. Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
    Lanzi R; Luzi L; Caumo A; Andreotti AC; Manzoni MF; Malighetti ME; Sereni LP; Pontiroli AE
    Metabolism; 1999 Sep; 48(9):1152-6. PubMed ID: 10484056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone binding protein activity in obese children.
    Seminara S; Filpo A; La Cauza F; Faedda A; Miola A; Pellizzone S; Casati M; Loche S
    J Endocrinol Invest; 1998; 21(7):441-4. PubMed ID: 9766258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic responses to exogenous ghrelin in obesity and early after Roux-en-Y gastric bypass in humans.
    Tamboli RA; Antoun J; Sidani RM; Clements A; Harmata EE; Marks-Shulman P; Gaylinn BD; Williams B; Clements RH; Albaugh VL; Abumrad NN
    Diabetes Obes Metab; 2017 Sep; 19(9):1267-1275. PubMed ID: 28345790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
    Denko CW; Malemud CJ
    Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic effects of adjuvant recombinant human growth hormone in patients with continuing sepsis receiving parenteral nutrition.
    Bettany GE; Camacho-Hubner C; Obeid O; Halliday D; Powell-Tuck J
    JPEN J Parenter Enteral Nutr; 1998; 22(4):199-205. PubMed ID: 9661119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients.
    Cappiello V; Ronchi C; Morpurgo PS; Epaminonda P; Arosio M; Beck-Peccoz P; Spada A
    Eur J Endocrinol; 2002 Aug; 147(2):189-94. PubMed ID: 12153739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth hormone insulin-like growth factor 1 axis in children and adolescents with inflammatory bowel disease and growth retardation.
    Wong SC; Smyth A; McNeill E; Galloway PJ; Hassan K; McGrogan P; Ahmed SF
    Clin Endocrinol (Oxf); 2010 Aug; 73(2):220-8. PubMed ID: 20184596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.